Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study.
Arthritis Center.
Kimberly T
KT
Finch
Arthritis Center.
Eric A
EA
Stratton
Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts.
Harrison W
HW
Farber
D000368:Aged; D002317:Cardiovascular Agents / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D010865:Pilot Projects; D000069458:Ranolazine / Q000627:therapeutic use*; D013318:Stroke Volume / Q000502:physiology*
D002317:Cardiovascular Agents; D000069458:Ranolazine